Avava, a Waltham, MA-based medical aesthetics platform company, raised $35M in financing.
The round consisted of $25M in proceeds from new and existing investors including its strategic partner, Jeisys Medical, Inc, and $10M in growth capital from Catalio Capital Management.
The company intends to use the funds to further accelerate the commercialization of its flagship product, MIRIA, a new class of aesthetic dermatology lasers utilizing proprietary Focal Point Technology™ to deliver energy with pinpoint accuracy anywhere in the skin, enhancing skin revitalization outcomes for patients of all skin tones.
Led by CEO Dr. Irina Erenburg, Avava is offering a new class of intradermal lasers that enable customization. By creating a map to personalized skin care through proprietary and patented Focal Point Technology™, and guided by advanced skin imaging, laser energy is delivered at the precise therapeutic depth for optimal results for all skin tones and types.
FinSMEs
13/06/2024